Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-14

Clinical Trial Update: Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of liraglutide on diastolic dysfunction in type 2 diabetes patients, assessed by cardiac MRI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Diabetes Mellitus Type 2, Diastolic Dysfunction | Phase 4 | Status: COMPLETED